Cargando…
Clinical and genomic characteristics of metabolic syndrome in colorectal cancer
Metabolic syndrome (MetS) is characterized by a group of metabolic disturbances which leads to the enhanced risk of cancer development. Elucidating the mechanisms between these two pathologies is essential to identify the potential therapeutic molecular targets for colorectal cancer (CRC). 716 color...
Autores principales: | Li, Yanyan, Zhao, Jungang, Wu, Xiaoli, Zhang, Yini, Jin, Yin, Cai, Weiyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950286/ https://www.ncbi.nlm.nih.gov/pubmed/33582655 http://dx.doi.org/10.18632/aging.202474 |
Ejemplares similares
-
Integration of clinical and transcriptomics reveals programming of the lipid metabolism in gastric cancer
por: Li, Yanyan, et al.
Publicado: (2022) -
Association between CT-Quantified Body Composition and Recurrence, Survival in Nonmetastasis Colorectal Cancer Patients Underwent Regular Chemotherapy after Surgery
por: Ying, Piaopaio, et al.
Publicado: (2021) -
Immune Infiltration Landscape in Lung Squamous Cell Carcinoma Implications
por: Zhao, Jungang, et al.
Publicado: (2020) -
Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma
por: Cai, Weiyang, et al.
Publicado: (2021) -
Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer
por: Meng, Yongsheng, et al.
Publicado: (2021)